About
Overview
Management
Board of Directors
Scientific Advisory Board
Our Science
iNKT Cells
ARDS & Infectious Diseases
Cancer
GvHD
Publications
Platform
Manufacturing
Engineering
Pipeline
Investor & Media
Overview
Press Releases
Events and Presentations
Stock Information
Financials & Filings
Corporate Governance
Careers
Contact
Home
Publications
Publications
SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 2020
AgenT-797, a novel allogenic and “off-the shelf” iNKT cell therapy promotes effective tumor killing,
B. Yigit, et al.
Poster
•
November 11 - 14, 2020
SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 2019
Discovery and characterization of the first fully-human Phosphopeptide Tumor Target-specific T cell receptor,
X. Michelet, et al.
Poster
•
November 7 - 10, 2019
Invariant natural killer T cells as an allogeneic cell therapy platform,
B. Yigit, et al.
Poster
•
November 7 - 10, 2019